Abstract
Studies on schizophrenia feature diffusion magnetic resonance imaging (dMRI) to investigate white matter (WM) anomalies. The heterogeneity in the possible interpretations of typical Diffusion Tensor Imaging (DTI) metrics highlights the importance of increasing their specificity. Here, we characterize WM pathology in early psychosis (EP) and schizophrenia (SZ) with increased specificity using advanced dMRI: Diffusion Kurtosis Imaging and the biophysical model White Matter Tract Integrity – Watson (WMTI-W). This enables us to better characterize WM abnormalities and relate them to the patient’s clinical characteristics and symptomatology. dMRI-derived microstructure features were extracted from all of WM and from individual tracts in 275 individuals. 93 subjects diagnosed with EP and 47 with SZ were compared respectively to 135 age-range matched healthy controls (HC). The relationships between the microstructure in WM and age at onset, aging trajectories, duration of illness, medication and various clinical scales were investigated in each patient group. WM diffusivities were higher, while kurtosis was lower in EP vs HC and in SZ vs HC. Differences were more pronounced in EP than SZ. WMTI-W model parameters suggest alterations to the extra-axonal compartment in EP and SZ as compared to HC. dMRI patterns in EP and SZ highly suggest WM deterioration in comparison to HC. The microstructure metrics involved point towards extra-axonal alterations, consistent with abnormal myelin integrity and WM deterioration. The direct link to symptomatology is however limited.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swiss National Science Foundation (PCEFP2-194260, to I.J.), the National Center of Competence in Research (NCCR) SYNAPSY - The Synaptic Bases of Mental Diseases from the Swiss National Science Foundation (n 51NF40 - 185897 to KQD & PC) and the Foundation Alamaya. Dr Alameda is supported by Carigest fellowship and by Frutiger Adrian et Simone fellowship. The authors have nothing to disclose and there are no conflicts of interest. Dr Dwir is supported by Frutiger Adrian et Simone fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in accordance with the Declaration of Helsinki and approved by the local Ethics Committee of the Canton of Vaud (Switzerland) under authorization numbers CER-VD 382/11 and 2018-01731.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The manuscript was completely revised, incorporating changes suggested by the co-authors. The correlations with the symptomatology was made more relevant as well correlation with clinical variables were tested
Data Availability
Data is not available for public use.